Tofacitinib 5 mg (Tofacent): Medicine Overview
Tofacitinib 5 mg, marketed under the brand name Tofacent, is a medication belonging to the Janus kinase (JAK) inhibitors class. While primarily approved for autoimmune conditions such as rheumatoid arthritis and psoriatic arthritis, emerging research has explored its potential in managing cancer, particularly liver and breast cancer. Tofacitinib ta